(Q59616706)
Statements
Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12 (English)
B Mlineritsch
H Stoeger
G Luschin-Ebengreuth
M Knauer
M Moik
R Jakesz
M Seifert
S Taucher
V Bjelic-Radisic
M Balic
H Eidtmann
W Eiermann
G Steger
W Kwasny
P Dubsky
U Selim
G Hochreiner
V Wette
P Sevelda
F Ploner
R Bartsch
C Fesl
R Greil
Austrian Breast and Colorectal Cancer Study Group, Vienna, Austria
17 November 2014